Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein-Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjögren's syndrome patients with pulmonary involvements.
Associations of Epstein-Barr virus (EBV) and autoimmune diseases have been hypothesized. We have analysed IgG antibodies to EBV nuclear antigen (EBNA)-2 in sera from Japanese patients with autoimmune systemic connective tissue diseases (CTD), exemplified by systemic lupus erythematosus (SLE), primary Sjogren's syndrome (SS), rheumatoid arthritis (RA), systemic sclerosis (SSc) and secondary SS (classical CTDs complicated with SS). An enzyme-linked immunosorbent assay (ELISA) which uses glutathione-S-transferase polypeptides fused to EBV nuclear antigen (EBNA)-2 and EBNA-1 was developed. Ratios of IgG antibody reactivity to whole IgG concentrations of sera were calculated to normalize EBNA-2 and EBNA-1 antibody levels to the hypergammaglobulinaemia that occurs in CTD. The ELISA optical density OD(450) readings of IgG antibodies to both the amino-terminal aa 1-116 of EBNA-2 and carboxyl-terminal aa 451-641 of EBNA-1 were elevated significantly in patients with SLE, primary SS, RA, SSc and secondary SS when compared to EBNA-1. The OD readings were divided by serum IgG concentrations to normalize for the hypergammaglobulinaemia. The specific levels of IgG antibodies to the amino-terminal region of EBNA-2 were elevated in patients with SLE, primary SS or RA, as well as those with secondary SS complicated with SLE or RA. The EBNA-2 amino-terminal region contains a polyproline tract and a proline-rich sequence and has considerable amino acid sequence homology with many cellular proline-rich proteins. High ratios of EBNA-2 aa 1-116 to EBNA-1 aa 451-641 IgG antibody levels which probably suggest reactivation of EBV latent infection were associated significantly with pulmonary involvement in SS patients. These results are consistent with the hypothesis that the sequence similarity between the amino-terminal region of EBNA-2 and proline-rich cellular proteins is associated with pathogenesis in a subpopulation of CTD patients, possibly by the molecular mimicry-epitope shift mechanism.
Yamazaki
M
M
Herpesvirus Laboratory, Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.
Kitamura
R
R
Kusano
S
S
Eda
H
H
Sato
S
S
Okawa-Takatsuji
M
M
Aotsuka
S
S
Yanagi
K
K
D000328:Adult; D000914:Antibodies, Viral / Q000097:blood*; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000821:virology; D016022:Case-Control Studies; D003240:Connective Tissue Diseases / Q000276:immunology* / Q000821:virology; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D020031:Epstein-Barr Virus Infections / Q000276:immunology; D019309:Epstein-Barr Virus Nuclear Antigens / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood*; D008168:Lung / Q000276:immunology*; D008180:Lupus Erythematosus, Systemic / Q000276:immunology / Q000821:virology; D012859:Sjogren's Syndrome / Q000276:immunology / Q000821:virology; D018709:Statistics, Nonparametric; D014764:Viral Proteins; D017735:Virus Latency
D000914:Antibodies, Viral; C402641:EBNA-2 protein, Human herpesvirus 4; D019309:Epstein-Barr Virus Nuclear Antigens; D007074:Immunoglobulin G; D014764:Viral Proteins
Arthritis Rheum. 1999 Dec;42(12):2569-76
10616002
Arthritis Rheum. 1990 Jul;33(7):993-1000
2164400
J Rheumatol. 2000 Apr;27(4):866-73
10782808
Arch Immunol Ther Exp (Warsz). 2000;48(5):347-51
11140461
Arthritis Rheum. 2001 May;44(5):1122-6
11352244
Adv Virus Res. 2001;56:199-217
11450300
Am J Respir Crit Care Med. 2002 Jan 15;165(2):277-304
11790668
J Mol Med (Berl). 2001 Dec;79(12):722-31
11862315
Nat Rev Immunol. 2002 Feb;2(2):85-95
11910899
Scand J Rheumatol Suppl. 2002;116:23-7
12109539
Arthritis Rheum. 2002 Jul;46(7):1866-72
12124871
J Virol. 2003 Mar;77(6):3824-31
12610157
Clin Diagn Lab Immunol. 2004 Jan;11(1):123-30
14715558
Proc Natl Acad Sci U S A. 2004 Jan 27;101(4):1033-8
14732686
N Engl J Med. 1975 Feb 20;292(8):403-7
1089199
N Engl J Med. 1975 Feb 13;292(7):344-7
1090839
Chest. 1976 Sep;70(03):354-61
989035
Lancet. 1979 Mar 10;1(8115):549
85124
Arthritis Rheum. 1980 May;23(5):581-90
7378088
Arthritis Rheum. 1982 Nov;25(11):1271-7
7138600
Nature. 1984 Jul 19-25;310(5974):207-11
6087149
J Virol. 1984 Oct;52(1):88-93
6090712
J Immunol. 1985 Jan;134(1):211-6
2981091
Proc Natl Acad Sci U S A. 1985 Sep;82(18):6300-4
2412231
J Clin Invest. 1986 May;77(5):1539-47
2422209
J Gen Virol. 1986 Oct;67 ( Pt 10):2253-8
3020161
J Rheumatol. 1990 Nov;17(11):1442-9
2177109
J Infect Dis. 1991 Jul;164(1):22-8
1647426
J Clin Microbiol. 1992 Jun;30(6):1442-8
1320628
Arthritis Rheum. 1993 Mar;36(3):340-7
8452579
J Rheumatol. 1993 May;20(5):831-7
8336308
Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):12010-4
8265662
J Exp Med. 1995 Feb 1;181(2):453-61
7530756
J Exp Med. 1995 Jul 1;182(1):75-85
7540658
J Immunol. 1996 May 1;156(9):3480-5
8617976
J Rheumatol. 1996 Jun;23(6):1088-94
8782145
J Exp Med. 1996 Nov 1;184(5):1791-800
8920867
Nucleic Acids Res. 1997 Sep 1;25(17):3389-402
9254694
J Rheumatol. 1997 Nov;24(11):2090-6
9375865
J Clin Invest. 1997 Dec 15;100(12):3019-26
9399948
Clin Exp Rheumatol. 1998 May-Jun;16(3):289-94
9631751
Rev Rhum Engl Ed. 1998 Jun;65(6):365-8
9670326
Clin Exp Rheumatol. 1998 Jul-Aug;16(4):409-15
9706420
Immunol Rev. 1998 Aug;164:93-100
9795767
Immunol Rev. 1998 Aug;164:185-200
9795776
J Autoimmun. 1998 Oct;11(5):431-8
9802926
J Immunol. 1999 Mar 15;162(6):3694-701
10092832
Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):5164-8
10220436
Autoimmunity. 1999;30(1):53-9
10433095
J Immunol. 1986 Nov 15;137(10):3162-8
3021847
J Immunol. 1987 Jan 15;138(2):593-9
2432130
Proc Natl Acad Sci U S A. 1987 Jan;84(2):570-4
3025881
J Exp Med. 1987 Apr 1;165(4):1026-40
2435830
Br J Rheumatol. 1987 Jun;26(3):193-6
3034370
J Rheumatol Suppl. 1987 Jun;14 Suppl 13:112-7
2441042
Cell. 1987 Sep 11;50(6):819-20
3621346
Int J Cancer. 1987 Sep 15;40(3):349-53
3040599
J Virol. 1988 Jan;62(1):100-5
2446012
Rheum Dis Clin North Am. 1987 Aug;13(2):275-92
2827246
Arthritis Rheum. 1988 Mar;31(3):315-24
3358796
Ann N Y Acad Sci. 1988;540:210-7
2462803
Int J Cancer. 1989 Jun 15;43(6):1017-21
2543639
J Autoimmun. 1989 Jun;2 Suppl:187-94
2673272
Brain. 2000 Mar;123 Pt 3:508-18
10686174